Remote Brief Intervention and Referrals to Treatment Service for Alcohol
RBIRT
1 other identifier
interventional
330
1 country
1
Brief Summary
The traditional paradigm that relies upon training physicians and nurses or uses on-site interventionists to perform screening, brief intervention, and referral to treatment (SBIRT) for alcohol has proven unsustainable in most clinical settings. The Remote Brief Intervention and Referral to Treatment (R-BIRT) for alcohol is an innovative telehealth service model with potential to improve public health through evidence based counseling for patients who exceed the NIAAA low risk drinking limits or have evidence of an Alcohol Use Disorder with professional and self-help treatment. For those that are appropriate, the R-BIRT service will provide facilitated referrals to specialized alcohol abuse treatment. The service model is being studied in the emergency department (ED) setting to demonstrate its utility in a medical setting with a very high prevalence of risky alcohol use and Alcohol Use Disorders; however, the model is relevant and will be accessible to a broad array of healthcare settings, including primary care practices. Our new model, the R-BIRT, challenges the prevailing paradigm and offers the promise of not only clinical efficacy but increased cost effectiveness as well.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Mar 2017
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2015
CompletedFirst Posted
Study publicly available on registry
December 7, 2015
CompletedStudy Start
First participant enrolled
March 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2020
CompletedMarch 10, 2021
March 1, 2020
3.4 years
November 19, 2015
March 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in alcohol use across the study period compared to baseline.
Consistent with the latest standards in ED SBIRT research, alcohol use will be measured by a one-week Timeline Follow-back (TLFB), which is a validated procedure wherein participants report the number of drinks they consumed each day for the past seven days using a protocol that facilitates recall. This will allow computation of drinks/week and drinking above the NIAAA low risk drinking limits.
1,3, 6 months post Emergency Department (ED) visit
Secondary Outcomes (3)
Changes in alcohol related consequences across the study period compared to baseline.
1,3,6 months post ED visit
Changes in acute healthcare utilization at 6 months compared to baseline.
6 months post ED visit
Compare the costs of both interventions: SBIRT and RBIRT.
6 months post ED visit
Study Arms (2)
RBIRT
EXPERIMENTALTelehealth model or the remote administration of SBIRT, a short term, brief intervention and referral to treatment for alcohol abuse.
SBIRT
ACTIVE COMPARATORFace-to-face intervention and referral to treatment for alcohol abuse.
Interventions
Eligibility Criteria
You may qualify if:
- years old or older.
- Presenting for care to the UMass Emergency Department.
- Screens positive for alcohol use above the NIAAA age and gender matched low risk drinking limits.
- AUDIT-10 score greater than 8 suggesting risk for an Alcohol Use Disorder.
You may not qualify if:
- Altered mental status (not alert, not oriented, psychotic, persistent intoxication).
- Patients who present as initially intoxicated but who are no longer intoxicated later in the visit can be approached.
- Currently in alcohol treatment.
- DAST-10 score greater than 3.
- Currently in state custody or pending legal action that might lead to imprisonment.
- Cannot paraphrase the study requirements.
- No reliable telephone access.
- Does not speak English.
- Already enrolled into the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Polaris Health Directionslead
- University of Massachusetts, Worcestercollaborator
Study Sites (1)
University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edwin D Boudreaux, PhD
University of Massachusetts, Worcester
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2015
First Posted
December 7, 2015
Study Start
March 22, 2017
Primary Completion
August 31, 2020
Study Completion
August 31, 2020
Last Updated
March 10, 2021
Record last verified: 2020-03